ChemoMetec
ISIN: DK0060055861 | Ticker: CHEMM | LEI: 213800533NBKECGONO68
Country: Denmark
ChemoMetec is a worldwide leading manufacturer of cell counting and analysis equipment. We specialize in developing and producing high-precision instrumentation, delivering consistent data for thousands of customers across biotech, pharma and academic segments.
We are experiencing exponential growth, as the company strives towards our goal to be the number one provider in Life Sciences.
Designed, manufactured and tested in Denmark, our instruments and consumables are built with quality materials and dedicated expert workmanship.
1997
Served areaWorldwide
HeadquartersGydevang 43, 3450 Allerod – Denmark
| Line item in (dkk) | 02.07.2020 | 01.07.2021 | 02.07.2021 | 01.01.2022 | 01.07.2022 | 02.07.2022 | 01.01.2023 |
|---|---|---|---|---|---|---|---|
| Assets | N/A | 344,909,000.00 | N/A | 371,205,000.00 | 501,273,000.00 | N/A | 556,737,000.00 |
| Noncurrent Assets | N/A | 100,552,000.00 | N/A | 132,645,000.00 | 148,338,000.00 | N/A | 158,435,000.00 |
| Property Plant And Equipment | N/A | 42,496,000.00 | N/A | 69,781,000.00 | 74,783,000.00 | N/A | 84,036,000.00 |
| Land And Buildings | N/A | 24,172,000.00 | N/A | 48,457,000.00 | 48,392,000.00 | N/A | 59,991,000.00 |
| Machinery | N/A | 11,692,000.00 | N/A | 15,029,000.00 | 21,066,000.00 | N/A | 19,552,000.00 |
| Other Property Plant And Equipment | N/A | 6,632,000.00 | N/A | 6,295,000.00 | 5,326,000.00 | N/A | 4,492,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 57,884,000.00 | N/A | 62,566,000.00 | 67,398,000.00 | N/A | 74,076,000.00 |
| Copyrights Patents And Other Industrial Property Rights Service And Operating Rights | N/A | 2,269,000.00 | N/A | 2,100,000.00 | 1,928,000.00 | N/A | 1,821,000.00 |
| Intangible Assets Under Development | N/A | 22,911,000.00 | N/A | 30,927,000.00 | 39,096,000.00 | N/A | 49,045,000.00 |
| Current Tax Assets Noncurrent | N/A | N/A | N/A | N/A | 5,854,000.00 | N/A | N/A |
| Longterm Deposits | N/A | 172,000.00 | N/A | 298,000.00 | 303,000.00 | N/A | 323,000.00 |
| Current Assets | N/A | 244,357,000.00 | N/A | 238,560,000.00 | 352,935,000.00 | N/A | 398,301,000.00 |
| Inventories | N/A | 30,113,000.00 | N/A | 45,588,000.00 | 66,790,000.00 | N/A | 92,860,000.00 |
| Other Current Receivables | N/A | 12,005,000.00 | N/A | 23,005,000.00 | 3,669,000.00 | N/A | 3,801,000.00 |
| Cash and cash equivalents | 96,941,000.00 | 150,109,000.00 | 150,109,000.00 | 114,732,000.00 | 209,025,000.00 | 209,025,000.00 | 224,422,000.00 |
| Cash | N/A | 150,109,000.00 | N/A | 114,732,000.00 | 209,025,000.00 | N/A | 224,422,000.00 |
| Equity And Liabilities | N/A | 344,909,000.00 | N/A | 371,205,000.00 | 501,273,000.00 | N/A | 556,737,000.00 |
| Equity | 202,751,000.00 | 264,977,000.00 | 264,977,000.00 | 282,609,000.00 | 357,205,000.00 | 357,205,000.00 | 457,190,000.00 |
| Issued Capital | N/A | 17,402,000.00 | N/A | 17,402,000.00 | 17,402,000.00 | N/A | 17,402,000.00 |
| Other Reserves | N/A | 247,575,000.00 | N/A | 265,207,000.00 | 339,803,000.00 | N/A | 439,788,000.00 |
| Liabilities | N/A | 79,932,000.00 | N/A | 88,596,000.00 | 144,068,000.00 | N/A | 99,547,000.00 |
| Noncurrent Liabilities | N/A | 7,959,000.00 | N/A | 11,146,000.00 | 6,690,000.00 | N/A | 7,821,000.00 |
| Other Longterm Provisions | N/A | 1,290,000.00 | N/A | 1,390,000.00 | 1,830,000.00 | N/A | 2,030,000.00 |
| Deferred Tax Liabilities | N/A | 5,757,000.00 | N/A | 6,333,000.00 | N/A | N/A | 1,279,000.00 |
| Current Liabilities | N/A | 71,973,000.00 | N/A | 77,450,000.00 | 137,378,000.00 | N/A | 91,726,000.00 |
| Trade And Other Current Payables | N/A | 8,710,000.00 | N/A | 11,505,000.00 | 17,023,000.00 | N/A | 12,650,000.00 |
| Current Tax Liabilities Current | N/A | 21,937,000.00 | N/A | 23,445,000.00 | 54,622,000.00 | N/A | 22,659,000.00 |
| Other Current Liabilities | N/A | 21,246,000.00 | N/A | 14,696,000.00 | 30,176,000.00 | N/A | 11,902,000.00 |
| Current Loans Received And Current Portion Of Noncurrent Loans Received | N/A | 592,000.00 | N/A | 713,000.00 | 1,025,000.00 | N/A | 941,000.00 |
| Line item in (dkk) | 01.07.2020/ 01.07.2021 |
01.07.2021/ 01.01.2022 |
01.07.2021/ 01.07.2022 |
01.07.2022/ 01.01.2023 |
|---|---|---|---|---|
| Revenue | 281,127,000.00 | 209,807,000.00 | 427,160,000.00 | 240,603,000.00 |
| Other Income | N/A | N/A | 1,231,000.00 | 2,054,000.00 |
| Other Work Performed By Entity And Capitalised | 9,547,000.00 | 5,737,000.00 | 11,216,000.00 | 5,445,000.00 |
| Raw Materials And Consumables Used | 37,330,000.00 | 33,852,000.00 | 55,354,000.00 | 35,377,000.00 |
| Employee Benefits Expense | 94,273,000.00 | 47,728,000.00 | 120,060,000.00 | 45,384,000.00 |
| Depreciation And Amortisation Expense | 19,607,000.00 | 9,684,000.00 | 20,038,000.00 | 10,478,000.00 |
| Other Expense By Nature | 23,441,000.00 | 18,033,000.00 | 41,301,000.00 | 22,100,000.00 |
| Profit Loss From Operating Activities | 116,023,000.00 | 106,247,000.00 | 202,854,000.00 | 134,763,000.00 |
| Finance Costs | 4,210,000.00 | 775,000.00 | 1,518,000.00 | 851,000.00 |
| Profit Loss Before Tax | 112,733,000.00 | 109,134,000.00 | 203,220,000.00 | 135,949,000.00 |
| Income Tax Expense Continuing Operations | 24,379,000.00 | 23,949,000.00 | 43,751,000.00 | 30,526,000.00 |
| Profit (loss) | 88,354,000.00 | 85,185,000.00 | 159,469,000.00 | 105,423,000.00 |
| Line item in (dkk) | 01.07.2021 | 02.07.2020 | 01.01.2022 | 01.07.2022 | 02.07.2021 | 01.01.2023 | 02.07.2022 |
|---|---|---|---|---|---|---|---|
| Profit (loss) | 88,354,000.00 | N/A | 85,185,000.00 | 159,469,000.00 | N/A | 105,423,000.00 | N/A |
| Adjustments For Depreciation And Amortisation Expense | 19,607,000.00 | N/A | 9,684,000.00 | 20,038,000.00 | N/A | 10,478,000.00 | N/A |
| Interest Paid Classified As Operating Activities | 918,000.00 | N/A | 775,000.00 | 1,518,000.00 | N/A | 634,000.00 | N/A |
| Interest Received Classified As Operating Activities | 88,000.00 | N/A | 1,000.00 | 9,000.00 | N/A | 217,000.00 | N/A |
| Income Taxes Paid Refund Classified As Operating Activities | 16,569,000.00 | N/A | 21,492,000.00 | 27,634,000.00 | N/A | 51,619,000.00 | N/A |
| Cash Flows From Used In Operating Activities | 107,901,000.00 | N/A | 67,050,000.00 | 176,860,000.00 | N/A | 48,247,000.00 | N/A |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | N/A | N/A | 38,000.00 | N/A | N/A | N/A | N/A |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | 11,249,000.00 | N/A | 33,220,000.00 | 39,101,000.00 | N/A | 13,691,000.00 | N/A |
| Purchase Of Intangible Assets Classified As Investing Activities | 13,373,000.00 | N/A | 8,342,000.00 | 16,815,000.00 | N/A | 10,313,000.00 | N/A |
| Cash Flows From Used In Investing Activities | -24,683,000.00 | N/A | -41,650,000.00 | -56,046,000.00 | N/A | -24,023,000.00 | N/A |
| Proceeds From Borrowings Classified As Financing Activities | 168,000.00 | N/A | 121,000.00 | 433,000.00 | N/A | -84,000.00 | N/A |
| Payments Of Lease Liabilities Classified As Financing Activities | 854,000.00 | N/A | 854,000.00 | 1,729,000.00 | N/A | 1,393,000.00 | N/A |
| Dividends Paid Classified As Financing Activities | 26,104,000.00 | N/A | 69,610,000.00 | 69,610,000.00 | N/A | N/A | N/A |
| Other Inflows Outflows Of Cash Classified As Financing Activities | N/A | N/A | N/A | 1,895,000.00 | N/A | N/A | N/A |
| Cash Flows From Used In Financing Activities | -26,037,000.00 | N/A | -66,191,000.00 | -69,012,000.00 | N/A | -1,478,000.00 | N/A |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 57,181,000.00 | N/A | -40,791,000.00 | 51,802,000.00 | N/A | 20,253,000.00 | N/A |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -4,013,000.00 | N/A | 5,414,000.00 | 7,114,000.00 | N/A | -4,856,000.00 | N/A |
| Cash and cash equivalents | 150,109,000.00 | 96,941,000.00 | 114,732,000.00 | 209,025,000.00 | 150,109,000.00 | 224,422,000.00 | 209,025,000.00 |
Please note that some sums might not add up.
DK0060055861
LEI213800533NBKECGONO68
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.